ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

American Radium Society Scientific Papers and Posters 2014

American Radium Society Scientific Papers and Posters 2014

Technological Innovations: Benefits, Costs, and Impact on Training and Practice

Proceedings of the 96th Annual Meeting of the American Radium Society — americanradiumsociety.org

SCIENTIFIC PAPERS

(S001) Limb-Sparing Surgery and Intraoperative Radiotherapy in the Treatment of Primary, Nonmetastatic Extremity and Limb-Girdle Soft Tissue Sarcoma 

(S002) Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Soft Tissue Sarcoma Metastases

(S003) Disparities in Stage at Diagnosis and Survival in Adult Cancer Patients According to Insurance Status

(S004) Radiation Publications Underrepresented in High-Impact General Medical and Oncology Journals

(S005) Adjuvant Radiotherapy in Stage II Endometrial Carcinoma: Is Brachytherapy Alone Sufficient for Local Control?

(S006Extended-Field IMRT With Concomitant Boost for Node-Positive Cervical Cancer: Analysis of Regional Control Rate and Recurrence Pattern

(S007) Stereotactic Radiosurgery to the Brain With Concurrent BRAF Inhibitors for Melanoma Metastases

(S008Use of Mobile Devices for Creation of Survivorship Care Plans

(S009) Two-Year Outcomes Following Triapine Radiochemotherapy for Cervical Cancer

(S010Prospective and Real-Time Data Analysis of Image-Guided Radiotherapy Across a Multinational Pediatrics Consortium: Methodology and Considerations

(S011Comparison of Toxicities and Outcomes for Conventional and Hypofractionated Radiation Therapy for Early Glottic Carcinoma

(S012Prognostic Value of Radiographic Extracapsular Extension in Locally Advanced Non-Oropharyngeal Head and Neck Squamous Cell Cancers

(S013Adjuvant Radiation Therapy and Temozolomide for Anaplastic Gliomas: The Twelve-Year Washington University Experience

(S014Gamma Knife Stereotactic Radiosurgery in the Treatment of Brainstem Metastases

(S015) Temporal Lobe Radionecrosis After Skull Base Radiotherapy: Dose-Volume Predictors

(S016Head and Neck Second Primary Cancer Rates in the HPV Era: A SEER Analysis

(S017) Long-Term Outcome of Intensity-Modulated Radiation Therapy in Pediatric Craniopharyngioma 

(S018) Early Tumor Perfusion Changes Predict Time to Progression in Patients With Recurrent Low-Grade Gliomas Treated With Everolimus Under a Phase II Clinical Trial

(S019) Prospective Evaluation of Stereotactic Radiosurgery for Spinal Metastases in the Postoperative Setting

(S020) Availability of Single-Fraction Palliative Radiotherapy for Cancer Patients Receiving End-of-Life Care Within the Veterans Healthcare Administration

(S021) Central Versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary NonSmall-Cell Lung Cancer

(S022) Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients After Trimodality Therapy

(S023) Stage I Lung SBRT Clinical Practice Patterns

(S024) Correlation of Survival to CBCT-Based Tumor Response During Chemoradiation in Patients With Stage III NonSmall-Cell Lung Cancer

(S025) Radiation-Induced Increases in PARP1 Activity Predict for Long-Term Radiosensitization by PARP1 Inhibition in Preclinical Breast Cancer Models

(S026) Postmastectomy Radiation Therapy for T3N0 Breast Cancer: A SEER Analysis

(S027) Patterns of Failure for Rhabdomyosarcoma of the Perineal and Perianal Region

(S028) Sequential Short-Course Radiotherapy and FOLFOX Chemotherapy as Preoperative Therapy for Rectal Cancer Provides Increased DFS Compared With Historical Controls

(S029) Patient-Reported Voice and Speech Outcomes and Their Clinical and Dosimetric Predictors After Chemo-IMRT of Oropharyngeal Cancer: A Prospective Longitudinal Study

(S030) Utilization of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center

(S031) A Phantom-Based Simulator Approach to Improving the Quality of Prostate Brachytherapy Training

(S032) Stereotactic Body Radiation Therapy for Low-, Intermediate-, and High-Risk Prostate Cancer: Disease Control and Quality of Life at Six Years

(S033) Dose-Escalated Radiation Therapy With or Without Short-Course Androgen Deprivation for Intermediate-Risk Prostate Cancer

(S034) Do Sociodemographic Factors Influence Outcome in Prostate Cancer Patients Treated With External Beam Radiation Therapy (EBRT)?

(S035) Peripheral and Lymphatic Radiation (RT) Doses With Treatment on RTOG 9413: Immunosuppression or Scattered Doses and Death From Second Cancers?

(S036) The Low Alpha-Beta Ratio of Bladder Cancer: A Rationale for Hypofractionation

(S037) Changes in Mass Transport as an Early Marker of Response to Cytotoxic Therapy in Human Pancreatic Adenocarcinoma

(S038) Patient Tolerability and Acute Toxicity of Intensity-Modulated Radiation Therapy for Treatment of Carcinomas of the Biliary Tract

(S039) ALDH-Expressing Cancer Stem Cells Are Associated With Inferior Survival in Patients With Resected Pancreatic Adenocarcinoma Treated With Adjuvant Chemoradiation

(S040) Outcomes, Costs, and Patient Satisfaction in a Pancreatic Multidisciplinary Clinic: Can Multidisciplinary Oncology Models Deliver Higher Value Care?

(S041) The Effect of High-Dose Stereotactic Body Radiation Therapy on Liver Function in the Treatment of Primary and Metastatic Liver Malignancies Utilizing the Child-Pugh Score Classification

(S042) Changing Practice Patterns for Breast Cancer Radiotherapy With Clinical Pathways: An Analysis of Hypofractionation in a Large Integrated Cancer Center Network

(S043) RadiotypeDx: Validation of a Radiation Sensitivity Signature in Human Breast Cancer

(S044) Repeated Measures Analyses of the Common Terminology Criteria for Adverse Events (CTCAE v3.0)-Based Dermatitis Toxicities in Breast Cancer Patients Receiving Radiotherapy in a Phase III Randomized Trial of Mometasone Furoate, N06c4 (Alliance)

(S045) Breast Conservation Therapy in Early-Stage Female Breast Cancer Patients Aged Less Than 40 Is Not Inferior to Mastectomy: A Surveillance, Epidemiology, and End Results Data Analysis

(S046) Changes in Brachytherapy-Based APBI Patient Selection in the Period Immediately Before and After Publication of the ASTRO Consensus Statement

(S047) Racial and Ethnic Differences in the Diagnosis of Breast Cancer: Changes in Presenting Stage in Minority Populations in Florida From 19812009

(S048) Impact of Breast Cancer Subtype in Locoregional Outcomes in Stage III Locally Advanced Breast Cancer (LABC) Treated With Modern Multimodality Therapy

POSTERS

(P001) Triapine Radiochemotherapy Improves Survival in Women With Stage IIIb Cervical Cancer

(P002) Impact of Three Decades of Screening on Cervical Cancer Incidence

(P003) Isolated Port-Site Metastases Following Laparoscopic Hysterectomy for Endometrial Cancer: Outcomes of Patients Treated With Radiotherapy

(P004) Definitive Radiation in Early-Stage Endometrial Carcinoma

(P005) Time to Cervical Stent Placement as a Predictor of Prolonged Treatment Course in Patients Treated With Definitive Chemoradiation Therapy for Cervical Cancer

(P006) Comorbidities and Senior Oncology Patients: How Comorbidities Affect Older Women With Cervical Cancer

(P007) Safety and Tolerability of Adjuvant Radiation "Sandwiched" Between Carboplatin and Paclitaxel in Women With Uterine Carcinosarcoma

(P008) The Effect of Body Mass Index on Chemoradiation Treatment Outcomes in Cervical Carcinoma

(P009) Early-Stage Carcinosarcoma Treated With Adjuvant Radiotherapy and Chemotherapy

(P010) Clinical Outcomes in Patients With Early-Stage Uterine Clear-Cell Carcinoma

(P011) Efficacy and Morbidity of Temporary Iodine-125 Brachytherapy in Pediatric Rhabdomyosarcomas

(P012) National Trends in Surgery for Sinonasal Malignancy: The Effect of Hospital Volume on Short-Term Outcomes

(P013) Radiotherapy at End of Life in Children

(P014) Age and Gender Patterns in the Use of Anesthesia for Children Receiving Radiotherapy

(P015) Delayed Cerebrovasculopathy Due to Cranial Radiation Therapy for Pediatric Tumors

(P016) Management of Pediatric Intracranial Low-Grade Gliomas: Long-Term Follow-up After Radiation Therapy

(P017) Prolonged Progression-Free Survival for Surgically Managed P16-Negative Squamous Cell Carcinoma of the Oropharynx

(P018) Micronucleus Score in Buccal Smear of Premalignant Lesions of Oral Cancers in Smokers

(P019) Fractionated Robotic Stereotactic Radiosurgery for the Treatment of Benign Meningioma

(P020) The Effect of Dose on Pain Relief and Numbness With Robotic Stereotactic Radiosurgery for Trigeminal Neuralgia

(P021) Long-Term Survival in Patients With Brain Metastases: Fact or Fallacy?

(P022) Modern Management of Lymphoepithelioma of the Head and Neck

(P023) The Importance of Surgery and the Role of Radiation Therapy and Chemotherapy for Treatment of Oral Tongue Cancer

(P024) Proton Radiotherapy for Midline CNS Lesions: A Class Solution

(P025) Outcomes of Nonmelanoma Skin Cancer in Immunosuppressed Patients Treated With Surgery and Radiation Therapy

(P026) Limiting Radiotherapy to the Contralateral Retropharyngeal and High Level II Lymph Nodes in Head and Neck Squamous Cell Carcinoma Is Safe and Improves Quality of Life

(P027) Salvage of ‘Low-Risk’ Oral Tongue Failures Initially Managed With Surgery Alone—Importance of Recurrent Stage

(P028) Efficacy and Tolerability of Chemoradiation for Lymph Node-Positive Cutaneous Nonmelanoma Skin Cancer

(P030) Peritumoral Lymphatic Vessel Density as a Predictor of Progression-Free Survival in Locally Advanced Laryngeal/Hypopharyngeal Cancer 

(P031) Disease Control and Toxicity Outcomes for T4 Carcinoma of the Nasopharynx Treated With Intensity-Modulated Radiotherapy

(P032) Clinical Outcomes for Hybrid Forward and Inverse Planned IMRT for Supine Craniospinal Irradiation

(P034) Ethnic and Gender Disparities Among Limb Salvage Rates in Pediatric Sarcoma Patients

(P035) Outcomes in Patients With Hypopharyngeal Cancer Treated With Intensity-Modulated Radiation Therapy 

(P036) The Significance of Different Dose Fractionations in the Management of Optic Nerve Sheath Meningioma 

(P037) Impact of Serial DWI and ADC Measurements in Assessment of Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial 

(P038) 4π Noncoplanar Stereotactic Body Radiation Therapy for Head and Neck Cancers

(P039) Reirradiation for Recurrent Gliomas: The University of Miami Experience 

(P040) Gastrointestinal Impact of Proton Radiation to the Spine in Pediatric Patients 

(P041) Dosimetric Predictors of Hypothyroidism Development in Oropharynx Cancer Patients Treated With IMRT

(P042) Patterns of Failure in Node-Positive Thyroid Cancer 

(P043) Stereotactic Radiosurgery Following Resection of Brain Metastases: Optimizing Benefit and Minimizing Risk 

(P044) Feasibility of Preoperative SBRT for Chondrosarcomas and Chordomas

(P045) Involved-Nodal Radiation Therapy Leads to Lower Doses to Critical Organs at Risk Compared With Involved-Field Radiation Therapy

(P046) Use of Intensity-Modulated Radiotherapy (IMRT) With Daily Image Guidance and Reduced Treatment Margins Is the Most Significant Predictor of Reduced Late Toxicity in Patients With Human Papillomavirus–Associated (HPV+) Oropharyngeal Cancer

(P047) Dosimetric and Toxicity Analyses of Reirradiation for Recurrent Pediatric Brain Tumors 

(P048) Quality Assurance Assessment of Diagnostic and Therapy Simulation Computed Tomography Image Registration for Head and Neck Radiotherapy: Anatomic Region of Interest–Based Comparison of Rigid and Deformable Algorithms

(P049) Simultaneous Integrated Boost–Intensity- Modulated Radiation Treatment in Head and Neck Cancer: Outcomes From a Single-Institution Series

(P050) Hypothyroidism After Definitive Radiation Therapy for Oropharyngeal Cancer 

(P051) Correlative Study of Thyroid DVH and Incidence of Subsequent Thyroid Dysfunction After Head and Neck Radiotherapy 

(P052) Evaluation of Pseudoprogression in Juvenile Pilocytic Astrocytomas Treated With Proton Beam Radiotherapy 

(P053) Proton Irradiation for Pediatric Central Nervous System Malignancies: Radiation Treatment Effect Risks in High-Risk Patients

(P054) Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence After Definitive Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer

(P055) Stereotactic Body Radiation Therapy in Unbiopsied PET+ Pulmonary Tumors

(P056) VATS With HDR Intraoperative Brachytherapy for Chest Wall Tumors

(P057) Acute-Phase Response Before Treatment Predicts Radiation Esophagitis in Non–Small-Cell Lung Cancer

(P058) Stereotactic Body Radiotherapy for Non–Small-Cell Lung Cancer Patients With Central Lung Tumors: An Analysis of Outcomes and Toxicity

(P059) Increased Rates of Radiation Pneumonitis in Patients Receiving Stereotactic Ablative Radiotherapy for Central Versus Peripheral Lung Tumors

(P060) Evaluation of 4D-CT Acquisition Methods Designed to Reduce Artifacts

(P061) Activity Verification and Localization Using PET-CT for Patients Treated With Radioembolization

(P062) SUVmax and Early Radiographic Changes as Prognosticators for Progression-Free Survival in Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy

(P063) Multiple Course Stereotactic Ablative Body Radiotherapy for Non–Small-Cell Lung Cancer

(P064) Proton Beam Therapy Is Associated With a Lower Incidence of Acute High Grade Chemoradiation-Related Esophagitis in the Treatment of Esophageal Cancer

(P065) Metformin Use Does Not Affect Chemoradiotherapy-Associated Toxicity

(P066) The Role of PET/CT in Radiation Treatment Planning for Non–Small-Cell Lung Cancer: Results of a National Survey

(P068) CTC Levels as a Preliminary Biomarker for Non–Small-Cell Lung Cancer Patients Undergoing Radiation Therapy

(P069) Stereotactic Body Radiotherapy for T1 Versus T2 Non–Small-Cell Lung Cancers

(P070) Quantitative Analysis of Stereotactic Body Radiation Therapy (SBRT)-Induced Lung Injuries

(P071) SBRT Treatment of Central Chest Lesions: Experience at the University of California, San Francisco

(P072) Reducing Radiation Dose to the Breast in Female Patients Undergoing Stereotactic Body Radiotherapy for Lung Cancer

(P073) Helical Tomotherapy-Based Stereotactic Radiotherapy Is Safe and Effective in the Treatment of Peripheral Thoracic Tumors

(P075) Stereotactic Body Radiotherapy With and Without Pelvic Radiotherapy for Organ-Confined High-Risk Prostate Cancer

(P076) Stereotactic Body Radiation Therapy (SBRT) for the Primary Treatment of Localized Prostate Cancer

(P077) Evaluating the Face of Failure: A Model to Predict Prostate Cancer Recurrences Using PSA Trends Following Brachytherapy Implant

(P078) Using a Deformable Bladder Planning Contour Reduces Repeat CBCTs During Prostate Image-Guided Intensity-Modulated Radiation Therapy

(P079) Linac-Based SBRT Delivered in Five Fractions for Definitive Prostate Cancer Treatment Using VMAT and Flattening Filter-Free Beams: The Phase II Lankenau Experience

(P080) After the Thaw: Prostate IGRT Effectively Treats Cryotherapy Failures

(P081) An Analysis of Soft Tissue Anatomy and Tracking of the Prostate Using Transperineal Ultrasound

(P082) Photoacoustic Imaging for Improved Intraoperative Visualization of Prostate Brachytherapy Seeds

(P084) Prostate Volume > 60 Ml Increases Risk of Urinary Retention in Prostate Cancer Patients Undergoing High-Dose-Rate Brachytherapy Monotherapy

(P085) Exploiting Androgen-Induced DNA Double-Strand Breaks: Optimal Sequencing of Androgen Suppression and Radiation for Superior Tumor Control in the Treatment of Prostate Cancer

(P086) The First National Experience of TraceIT" Tissue Marker Placed Intravesically Under Local Anesthesia for Imaging Visualization of Recurrent Muscle-Invasive Transitional Cell Carcinoma for Targeted Radiotherapy

(P087) Early Experience of Radium-223 Treatment for Metastatic Castration-Resistant Prostate Cancer: A Preliminary Report

(P088) Feasibility and Efficacy of Trimodality Therapy in Patients With High-Risk Pathologic T2–3 N0 M0 Prostate Cancer: Preliminary Results of an Ongoing Phase I/II Trial

(P089) A Phase III Randomized Trial of MRI-Mapped Dose-Escalated Salvage Radiotherapy Postprostatectomy: The Maps Trial—An Initial Dosimetric Assessment

(P090) Comparison of Intraoperatively Built Custom-Linked (IBCL) Seeds to Free Seeds for Permanent Prostate Brachytherapy

(P091) The Clinical Significance of Overlap or Underlap of the Prescription Isodose Line and Prostate Contour in Brachytherapy for Low-Risk Prostate Adenocarcinoma

(P092) Initial Clinical Results of Intraoperatively Built Custom-Linked (IBCL) Seeds for Permanent Prostate Brachytherapy

(P093) Induction Chemotherapy Followed by Concurrent Full-Dose Gemcitabine and Intensity-Modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

(P094) Retrospective Analysis of Patients With Locally Advanced Unresectable Pancreatic Cancer (LAUPC) Treated With Chemotherapy Alone or Chemotherapy Combined With Radiation Therapy: The Indiana University Simon Cancer Center (IUSCC) Experience

(P095) Comparison of Toxicity and Treatment Outcomes in HIV-Positive Versus HIV-Negative Patients With Squamous Cell Carcinoma of the Anal Canal

(P096) Preoperative Radiation Dose Escalation for Rectal Cancer Improves Tumor Downstaging Without Significant Increase in Toxicity: A Matched-Pair Analysis

(P098) Dose-Painting Technique in SBRT of Hepatocellular Carcinoma of Unfavorable Locations: Feasibility and Outcomes

(P099) A Multidisciplinary Approach to the Management of Patients Diagnosed With Stage IV Anal Canal Cancer: A Multi-institutional Retrospective Study

(P100) Radiation Therapy Is Associated With Improved Survival In Patients With Localized Pancreatic Cancer S/P Whipple Procedure Without Increased Morbidity: Results of a Study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data

(P101) Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer: A 6-Year Update

(P102) Effectiveness and Toxicity of Yttrium-90 Microsphere Brachytherapy

(P103) Socioeconomic Status and Overall Survival Following Hepatocellular Carcinoma Diagnosis in an Urban Academic Cancer Center

(P104) Trends in the Use of Neoadjuvant Radiotherapy for Rectal Cancer in the Academic Versus Community Setting

(P105) Improving Clinical Outcomes in Definitive Treatment of Esophageal Cancer Using a Novel Endoesophageal 3-Tube HDR Technique

(P106) High Adherence to the NCCN Guidelines for Neoadjuvant Treatment of Stage II and III Rectal Cancer Patients at a Tertiary Cancer Center and Its Partnering Institutions

(P107) Duodenal Sparing Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: Technique, Toxicity, and Local Response

(P108) A Dosimetric Comparison of Endorectal Brachytherapy, Tomotherapy, Linac-Based Stereotactic Body Radiotherapy (SBRT), and Cyberknife for the Delivery of a Rectal Tumor Boost

(P109) FDG-PET Feature and Texture Analysis as Potential Predictors of Pathologic Outcome Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

(P110) Breast Cancer Before Age 40: Current Patterns in Clinical Presentation and Local Management

(P111) Accelerated Partial-Breast Irradiation With Multicatheter High-Dose-Rate Brachytherapy: Feasibility and Results in a Private Practice Cohort

(P112) Single-Institution Experience With Intrabeam IORT for Treatment of Early-Stage Breast Cancer

(P113) Age and Marital Status Are Associated With Choice of Mastectomy in Patients Eligible for Breast Conservation Therapy

(P115) Breast Cancer Laterality Does Not Influence Overall Survival in a Large Modern Cohort: Implications for Radiation-Related Cardiac Mortality

(P116) Bilateral Immediate DIEP Reconstruction and Postmastectomy Radiotherapy: Experience at a Tertiary Care Institution

(P117) Anatomical Variations and Radiation Technique for Breast Cancer

(P118) Metadherin Overexpression Is Associated With Improved Locoregional Control After Mastectomy

(P119) Effect of Economic Environment on Use of Postlumpectomy Radiation Therapy for Stage I Breast Cancer

(P120) Immediate Versus Delayed Reconstruction After Mastectomy in the United States Medicare Breast Cancer Patient

(P121) Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 20042009

(P122) Streamlining Referring Physicians Orders With Reflex Testing Significantly Decreases Time to Resolution for Abnormal Screening Mammograms

(P123) National Trends in the Local Management of Early-Stage Paget Disease of the Breast

(P124) Effect of Inhomogeneity on Cardiac and Lung Dose in Partial-Breast Irradiation Using HDR Brachytherapy

(P125) Breast Cancer Outcomes With Anthracycline-Based Chemotherapy for Residual Disease Burden After Full-Dose Neoadjuvant Chemotherapy and Surgery Followed by Radiation Treatment

(P126) Student Institute to Stimulate Interest in Radiological Sciences Academic Careers (SISIRSAC): A Novel Near-Peer Mentoring Approach

(P127) One-Year Experience of Electronic Brachytherapy for the Treatment of Nonmelanoma Skin Cancer

(P128) Bi-Institutional Cosmetic Outcome of Radiotherapy for Benign Lymphoepithelial Cysts of Parotid Glands in HIV Patients

(P129) Electronic Brachytherapy for Nonmelanomatous Skin Cancer: Report of First 565 Lesions

(P130) Implication of Treatment Approach Based on Histology of Thymic Tumors

(P131) The Role of Radiation Therapy in the Management of Neurogenic Heterotopic Ossification

(P132) Stereotactic Radiosurgery to Five or More Brain Metastases in Melanoma Patients

(P133) Variation in Insurance Status by Patient Demographics and Tumor Site Among the Top Twenty-Five Causes of Cancer

(P134) Can a Radiation Oncology Social Media Website Be Used to Convey Reliable Radiation Oncology Information?

(P135) Dose Escalation Using Conventional Versus IMRT Planning for Hypofractionated Palliative Radiation of Lumbosacral Bony Metastases

(P136) Uniting Publication Database Functions Across Three Existing Complex Organizations

(P137) Midlevel Providers in Radiation Oncology and Their Role in Brachytherapy

(P138) Yttrium-90 Radioembolization for Liver Metastasis From Neuroendocrine Cancer: A Single-Institution Retrospective Review

(P140) Comparison of Split-Field IMRT With Whole-Field VMAT and IMRT for Locally Advanced Head and Neck Cancer

(P141) Dosimetric Comparison of Volumetric-Modulated Arc Therapy With Step-and-Shoot Intensity-Modulated Radiation Therapy for Prostate Cancer

(P142) Complementary and Alternative Medicine in Radiation Oncology Training: From a Resident's Perspective

(P143) Advanced Glycation Endproducts: The Sweet Tooth of Radiation Toxicity

(P144) Prospective Assessment of Patient-Specific Pulmonary Radiation Pneumonitis

(P145) Application of Perfusion SPECT Image-Guided Planning and Clinical Outcomes in Locally Advanced Lung Cancers

(P146) Clinical Outcomes From Frameless StereotacticRadiosurgery of Arteriovenous Malformations Using High-Resolution 3-Dimensional Rotational Angiography

(P147) Long-Term Outcomes of High-Dose-Rate Interstitial Brachytherapy for Gynecologic Malignancies

(P148) The Use of Updated Dosimetric Guidelines and Independent Dose-Volume Histogram Analysis Improves Treatment Planning for Men Treated With Rapidarc Intensity-Modulated Radiation Therapy for Clinically Localized Prostate Cancer

(P149) Collimator Design and Optimization for an Ir-192 Based Small-Animal Irradiator

(P150) Assessment of Acute and Late Toxicities of Intracranial Stereotactic Radiosurgery in Multiple Sclerosis Patients

(P151) Poor Long-Term Sexual Recovery With Neoadjuvant Androgen Deprivation Therapy (NADT) Plus Radiotherapy: Results of a Multicenter, Prospective Study

(P152) Fiducial-Less SBRT of the Lung: VMAT Versus CK

(P153) Hypofractionated Radiation for Early Breast Cancer: What Are Reasonable Lung Dose Constraints in the Setting of 3-Dimensional Treatment Planning?

(P154) Variation in Severity of Acute Skin Toxicity by Race and Ethnicity in a Prospective Cohort of Patients Receiving Postmastectomy Radiation

Proceedings of the 96th Annual Meeting of the American Radium Society — americanradiumsociety.org

By clicking Accept, you agree to become a member of the UBM Medica Community.